Package 25021-791-20

Brand: lacosamide

Generic: lacosamide
NDC Package

Package Facts

Identity

Package NDC 25021-791-20
Digits Only 2502179120
Product NDC 25021-791
Description

10 VIAL, GLASS in 1 CARTON (25021-791-20) / 20 mL in 1 VIAL, GLASS

Marketing

Marketing Status
Marketed Since 2022-03-17
Brand lacosamide
Generic lacosamide
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "3cabc3ea-4c98-462e-ae04-ccc0ab25c7a7", "openfda": {"nui": ["N0000008486"], "unii": ["563KS2PQY5"], "rxcui": ["809974"], "spl_set_id": ["6b4536d0-5703-42b0-9f59-46a3e1b75b22"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, GLASS in 1 CARTON (25021-791-20)  / 20 mL in 1 VIAL, GLASS", "package_ndc": "25021-791-20", "marketing_start_date": "20220317"}], "brand_name": "LACOSAMIDE", "product_id": "25021-791_3cabc3ea-4c98-462e-ae04-ccc0ab25c7a7", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "25021-791", "dea_schedule": "CV", "generic_name": "LACOSAMIDE", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LACOSAMIDE", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "10 mg/mL"}], "application_number": "ANDA214301", "marketing_category": "ANDA", "marketing_start_date": "20220317", "listing_expiration_date": "20261231"}